High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

Leukemia. 2014 Nov;28(11):2263-7. doi: 10.1038/leu.2014.214. Epub 2014 Jul 9.

¹ Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
² Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
³ Department of Electronic and Information Engineering, Huazhong University of Science and Technology, Wuhan, China.
⁴ Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN, USA.

No abstract available

Publication types